Výsledky vyhledávání - "L. Snegireva"

Primary tumor (tumoral) calcification is a rare disease in the practice of a rheumatologist and orthopedist: experience with the use of an interleukin-1 inhibitor in combination with surgical correction

Autor: Rena Idrisova, Veronika V. Petukhova, Mikhail Kostik, Olga L. Krasnogorskaya, L. Snegireva, Evgeny N. Suspitsyn, Alexander G. Veselov

Publikováno v: Ortopediâ, Travmatologiâ i Vosstanovitelʹnaâ Hirurgiâ Detskogo Vozrasta, Vol 7, Iss 3, Pp 85-92 (2019)

Background. Primary tumoral calcinosis is an orphan disease. There are few data in the literature on the incidence of this disease, as well as clinical recommendations for treatment. Clinical case. This report presents the case of an 11.5-year-old bo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e8b89f0fe33f8f108c804a28b04999f
https://journals.eco-vector.com/turner/article/viewFile/12523/12967

Zobrazit plný text záznamu

POS1320 SAFETY AND EFFICACY OF RITUXIMAB IN PATIENTS WITH JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS: THE PRELIMINARY DATA OF RETROSPECTIVE COHORT STUDY

Autor: E. Kalashnikova, R. Raupov, N. Lybimova, E. Kuchinskaya, O. Kalashnikova, V. Chasnyk, T. Kornishina, L. Snegireva, E. Gaidar, V. Masalova, E. Isupova, M. Kaneva, M. Dubko, T. Likhacheva, L. Sorokina, M. Kostik

Publikováno v: Annals of the Rheumatic Diseases. 81:997.2-997

Backgroundjuvenile systemic lupus erythematosus (jSLE) is the most frequent pediatric connective tissue disease with multiorgan involvement and different outcomes and prognosis. Corticosteroids remain the base treatment option and steroid-sparing tre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5d25bc1718a3b214f64d267e38a4581b
https://doi.org/10.1136/annrheumdis-2022-eular.4061

Zobrazit plný text záznamu

POS1299 RISK FACTORS OF TOTAL HIP ARTHROPLASTY IN JUVENILE ARTHRITIS WITH HIP INVOLVEMENT

Autor: V. Masalova, Lubov Sorokina, Ilia Avrusin, M. Kostik, T. Likhacheva, I.A. Chikova, M. Gharabaghtsyan, R. Raupov, E. Gaidar, L. Snegireva, S. Khrypov, M. Dubko, N. Garipova, E. Isupova

Publikováno v: Annals of the Rheumatic Diseases. 80:931-932

Background:Hip osteoarthritis (HOA) is a severe outcome of juvenile idiopathic arthritis (JIA) itself and also can be result of corticosteroid (CS) treatment, if it was used. Total hip arthroplasty (THA) is the last step in JIA treatment and indicate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cbbbdeb68e6a1efda06a6399fdcc5def
https://doi.org/10.1136/annrheumdis-2021-eular.857

Zobrazit plný text záznamu

Proteomic Profile of Tears for the Diagnosis of Uveitis Associated with Juvenile Idiopathic Arthritis: Setting Targets to Achieve Results

Autor: Elena D Serogodskaia, V. Masalova, E. Gaidar, Olga Kalashnikova, Anatolii Viktorovich Kononov, Alla Hynes, Liudmila I Grebenkina, Tatiana N. Nikitina, Vyacheslav Chasnyk, Vladimir Keltsev, Tatyana Ammosova, L. Snegireva, Sergei Nekhai, Mikhail Kostik, M. Dubko, Yuri Obukhov, Xionghao Lin

Publikováno v: Pediatrician (St. Petersburg). 8:5-26

The paper presents epidemiologic and pathophysiological aspects of the problem statement for early recognition of Uveitis (Uv) associated with Juvenile Idiopathic Arthritis (JIA) in terms of the proteomic profile of tears as well as the results of an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ef58ab77aac0bf7e09a11892056b7ea1
https://doi.org/10.17816/ped815-26

Zobrazit plný text záznamu

AB1000 THE SURVIVAL OF METHOTREXATE IN JUVENILE IDIOPATHIC ARTHRITISCHILDREN AFTER DURING FIRST BIOLOGIC TREATMENT

Autor: Tatiana Likhacheva, Ilya Avrusin, E. Isupova, E. Gaidar, Elizaveta Orlova, Lubov Sorokina, Olga Kalashnikova, V. Masalova, Yuri Korin, M. Dubko, Tatiana Kornishina, L. Snegireva, R. Raupov, Mikhail Kostik

Publikováno v: Abstracts Accepted for Publication.

Background Methotrexate (MTX) is a gold standard for treatment of juvenile idiopathic arthritis (JIA) patients. The main adverse events (AE) related to the MTX are intolerance, increased rate of infections, elevation of the liver enzymes, hematologic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3541d703e61ed17e26eccecc1e605fa5
https://doi.org/10.1136/annrheumdis-2019-eular.5233

Zobrazit plný text záznamu

POS0080 TOFACITINIB TREATMENT IN CHILDREN WITH RHEUMATIC DISEASES: SINGLE-CENTER EXPERIENCE

Autor: R. Raupov, V. Masalova, Evgeny N. Suspitsin, Vyacheslav Chasnyk, Lubov Sorokina, T. Ermachenkova, T. Likhacheva, M. Kostik, Olga Kalashnikova, T. Gabrusskaya, E. Gaidar, M. Dubko, L. Snegireva, E. Isupova, M. Kaneva

Publikováno v: Annals of the Rheumatic Diseases. 80:247.1-248

Background:While efficacy of tofacitinib (TOF) has been proven in many adult immune-mediated conditions, the information on its’ safety and efficacy in the pediatric population is limited.Objectives:to evaluate the safety and efficacy of TOF in chi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9c2d018288c4dec182a345dbf1c14b21
https://doi.org/10.1136/annrheumdis-2021-eular.1913

Zobrazit plný text záznamu

POS1310 CANAKINUMAB IS A RESCUE TREATMENT FOR MACROPHAGE ACTIVATION SYNDROME IN PATIENTS WITH SYSTEMIC ONSET JUVENILE IDIOPATHIC ARTHRITIS: SINGLE CENTER EXPERIENCE

Autor: I.A. Chikova, M. Dubko, M. Kostik, M. Kaneva, L. Snegireva, T. Likhacheva, T.L. Kornishina, E. Isupova, Vyacheslav Chasnyk, Olga Kalashnikova, V. Masalova, E. Gaidar

Publikováno v: Annals of the Rheumatic Diseases. 80:937.1-937

Background:Macrophage activation syndrome (MAS) is a severe life-threatening complication of the systemic-onset juvenile idiopathic arthritis (soJIA). The treatment options included high-dose of the corticosteroids (CS), cyclosporine A (CsA), intrave

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::932361b1700df5a3a0ba1800b07565f2
https://doi.org/10.1136/annrheumdis-2021-eular.2141

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání